Toxicology meetings & conferences

2012 Annual Meeting of the North American Congress of Clinical Toxicology

The American Academy of Clinical Toxicology and the American Association of Poison Control Centers are pleased to announce that the North American Congress of Clinical Toxicology 2012 and associated pre-meeting functions will be held at The Cosmopolitan of Las Vegas located in Las Vegas, NV; October 1-6, 2012.

This annual conference allows an opportunity for physicians, pharmacists, nurses, and scientists from around the world to participate in the sharing of knowledge on a wide variety of clinical toxicology topics and issues. In addition, there will be multiple original research papers presented, a number of symposia, as well as other traditional and novel continuing education sessions.

General Objectives:

-- Identify the acute and/or chronic toxic effects of various drugs, chemicals and biologicals.

-- Utilize research data to determine new approaches to the prevention, assessment, and treatment of poisoning victims.

-- Compare and contrast approaches to the treatment of poisoned patients.

-- Identify the principles of assessing the severity and predicting the outcome of poisonings.

-- Define innovations in the responsibilities and functions of poison centers.

-- Identify the principles involved in the laboratory evaluation of poisonings.

-- Identify the risks and treatment of occupational and environmental hazards to humans.

Biannual Non-Clinical Statistics Conference

24-26 September 2012, Potsdam, Germany

Key Topics

-- Statistical methods in functional genomics
-- Design and analysis of drug stability studies
-- Statistical evaluation of studies in regulatory toxicology
-- Bioassays
-- Analysis of in-vitro and in-vivo studies for new non-neoplastic compounds
-- Transfer of analytical methods
-- Pharmacological studies
-- Bayesian statistics in pre-clinical drug development
-- Incorporating pre-clinical results in clinical development
-- Other non-clinical applications

Who should attend

Statisticians with an interest in the application of statistics to non-clinical areas of the drug development and production process. Whether you work in the pharmaceutical industry, contract research organizations, academia, regulatory and other government bodies, this event will be relevant to you.

Annual Biomedical Research Conference for Minority Students

November 7-10, 2012 San Jose, California

ABRCMS
American Society for Microbiology Education Department
1752 N Street, NW
Washington, DC 20036

Ph: 202-942-9348
Fax: 202-403-3513

Email:abrcms@asmusa.org

WCN 2013 XXI World Congress of Neurology

September 21-26, 2013 Vienna, Austria

Join leading neurologists at WCN 2013, the world’s biggest neurology event. The XXI World Congress of Neurology will feature a rich scientific programme, including the latest developments in clinical practice and research, distinguished plenary speakers, teaching courses, workshops, and lectures, all on the increasingly global aspect of our work.

List of Proposed Topics

Epilepsy (Joint WFN & ILAE)
Movement Disorders
Stroke (Joint WSO & WFN)
Neuro-critical care
Dementia
MS & Demyelinating Diseases
Neuromuscular disorders
Headache
Pain
Neurorehabilitation
Neurooncology
CNS infection
Vertigo and balance disorders
Sleep
Leukoencephalopathies & Child neurology
Autoimmune encephalitis
Neurology, Health economics & outcomes
Metabolic and mitochondrial diseases
Neuroepidemiology
Environment, Climate Change
Autonomic nervous system
Neuroophthalmology
Brain & Behavior
Motor neuron disease
Channelopathies
Palliative care
Nutritional disorders & Neurotoxins
Stem cells in Neurology, hopes, uses and abuses
Neurological surgery for the neurologist
Psychiatry for the neurologist
Neuroethics
Interventional Neuroradiology
Advances in Neuroimaging
Advances in Neurophysiology
Therapeutic Neurotoxins
Biomarkers
World History of Neurology
You Tube neurology
Movies and neurology
Sports neurology
Training in neurology around the world
WHO Neurology Initiatives (Noncommunicable disease Initiative, MhGAP Program, ICD-11 revision of neurology codes)
Cases from around the world
Making the Case for Neurology

Contact Us
Please email us at wcn@kenes.com for more information or any queries.
 

Nanosafe 2012

After the success of Nanosafe 2008 and Nanosafe 2010, the next edition Nanosafe 2012 will be held from 13th to 15th November 2012 in Minatec, Grenoble, France .

Topics

Exposure assessment
Detection and identification
Toxicology
Environmental interactions
Nanomaterials release
Protection technology
Industrial production
Life Cycle Analysis
Ethics and societal issues
Commercial equipements
Risk management for OHS experts

Programme
The three-day programme for this conference will comprise:

-- Invited plenary lectures

G. Oberdörster (U. ROCHESTER), D. Pui (U. MINNESOTA), D. Brouwer (TNO), T. Nhuyen (NIST), F. Schuster (CEA), B. Nowack (EMPA), R. Muir (NANEUM). D. Bernard (ARKEMA), J. Rose (CEREGE), C. Engeman (UCSB) A. Grobe (U. STUTTGART). A. Grinbaum (CEA), F. Roure (FRENCH MINISTRY FOR ECONOMY, FINANCE AND INDUSTRY), A. Kishimoto (AIST, RISS), C. EMOND (U. MONTREAL), L. Golanski (CEA), O. Witschger (INRS), E. Drais (INRS).

-- Selected oral contributions

- Posters sessions

-- Panel discussions: Governance/ Toxicology/ The opinion of the civil society regarding nanomaterials

-- Exhibition of equipments related to safe production and use of nanomaterials

-- Satellite meetings: TITNT, TRIMATEC, NANOHOUSE

International Symposium on Ocular Pharmacology and Therapeutics ISOPT Clinical 2013

March 7-10, 2013 Paris, France

ISOPT will reconvene in Paris March 7 – 10 for our 10th symposium. Over the years, ISOPT has repeatedly shaped its form so it can accommodate to provide a collaborative atmosphere for clinicians, clinical trialists, pharma industry and regulatory officers. Our formed vision has been to increase knowledge and awareness of drug usage in ophthalmology reflecting innovations and their utilization in practice. In order to achieve this vision ISOPT is set to implement the following missions:

Educate via updating and sharing current and evolving treatment algorithms for practitioners.

Connect data arising from clinical studies to actual daily practice.

Facilitate innovation via panels and discussions of early and late “development related topics”.

We invite you to join us in Paris, and become a part of ISOPT, bring your own experience and insights of treating your patients, be exposed to the last two year clinical experience gained in major industry supported studies and be part of the efforts to reflect scientific data to clinical reality and patient care.

ISOPT has become famous for its informal atmosphere and the ability to meet experts and faculty leaders for “out of the lecture hall” discussions.

Whether your field of interest is in retinal diseases, inflammation, cornea and external diseases, glaucoma or basic science you may contribute and be part of the ISOPT spirit.

Focused Update in Medical Management

Retina

Dry AMD

Wet AMD

Diabetic Retinopathy

Diabetic Macular Edema

Retinal Vein Occlusion

Retinal Degeneration

Devices & Drug Delivery

Inflammation & Infection
Allergic Conjunctivitis

Treatment Updates

Clinical Studies for Uveitis

Cases Presentation

Ocular Infections

Basic Science

Therapy of Neovascularization

Inhibition of Diabetic Retinopathy

Antioxidants and Nutrition

Vascular Targets

Gene Therapy

Glaucoma

Conventional & Potential Glaucoma Therapy

Glaucoma Therapy & Ocular Surface

Inraocular Pressure & Glaucoma

Blood Flow & Glaucoma

External Eye Diseases
Dry Eye Treatment Innovations

Dry Eye-Ocular Surface Clinical Trials

Wound Healing

External Eye Diseases

Anterior Segment Imaging

Devices

Drug Development

Drug Delivery

Imaging

Toxicology

Nano Technology

Regulation of Ophthalmic Products

Ethics

A platform for informal communication with experts in drug development

Symposium Secretariat

Paragon Conventions
18, Avenue Louis-Casai
1209 Geneva, Switzerland
Tel: +41 (0)22 5330 948
Fax: +41 (0)22 5802 953
Email: isopt@isopt.net

4th International Congress on Arsenic in the Environment

Understanding the Geological-Medical Interface of Arsenic

22-27 July 2012 Cairns, Australia

A. Geological theme
 Analytical challenge of arsenic speciation - e.g. geological matrix, food/water, marine biota etc
 Arsenic in marine realm
 Hydrogeology/sedimentological role on arsenic distribution/heterogeneity
 Mobility & transport of arsenic (environmental fate of arsenic & risk interface)
 Recent advances in x-ray spectroscopy (synchrotron) studies – geology aspect
 Release of arsenic into the groundwater
 Significance of geogenic and anthropogenic sources of arsenic
 Soil to water: geological aspects of Himalaya region

B. Medical/Health theme
 Arsenic and water quality
 Arsenic in medicine
 Bioavailability of arsenic in soil & food
 Early childhood effects
 Epidemiology
 Health intervention and treatment
 Mechanism of chronic arsenic poisoning
 Polymorphisms and health
 Recent advances in arsenic toxicology/biochemistry
 Significant of arsenic speciation with regard to health risk
 Social effects
 Synchrotron studies – health aspects

C. Special Sessions
 Arsenic biotransformation
 Arsenic issues related to mining e.g. deep sea discharge, mine site risk assessment, food web transfer,
remediation/intervention etc
 Geomicrobiology of arsenic
 Geothermal arsenic
 Management of environmental arsenic
 Regulatory perspective e.g. recent JECFA review and withdrawal of PTWI of arsenic
 Remediation and water treatment
 Rice CRM (Yongguan Zhou & Jack Ng, an action item of As2010 discussion group)

JKTech Pty Ltd
+61 7 3346 5919
As2012@jktech.com.au

2012 Healthy Buildings Conference

8 - 12 July 2012 Brisbane, Queensland, Australia

Conference Program

Following recommendations from the hard work already done by the Australia New Zealand Organising Committee, the International Advisory Committee and the Program Committee, the three days of the conference will be divided into three main topic areas/symposia:

Day 1: Balance of power: Energy Conservation versus Indoor Environmental Quality

Day 2: Race against Time: Population, Urban Growth and Miracles of Technology

Day 3: Infection spread: Will breathing kill you?

Topics

Comfort and climate (thermal comfort, perceived air quality, …)
Ventilation and controls (filtration, air cleaning, …)
Chemical pollutants (VOC, SVOC, …)
Particulate matter (Particles, Dust, …)
Regional solutions (developing countries, climate specific design, …)
Dampness and microbes (mould and bacteria, moisture control, mycotoxins, …)
Guidelines and policies (product safety, REACH, …)
Sustainable and green buildings (easy efficiency, materials and construction, Net Zero Buildings, …)
Productivity (human performance, perception, …)
Locations (public buildings, residential, …)
Human response (allergies, epidemiology, toxicology, …)
Basic processes/Fundamentals (sources/emissions, transport processes, …)
Impacts of outdoor air
Other

The Contribution of Epigenetics in Pediatric Environmental Health

Wednesday, May 30, 2012 - Friday, June 01, 2012 San Francisco, California

The conference will highlight the role of epigenetics in determining the impact of the environment on pediatric disease and children’s current and future health.

Conference Objectives:

To inform the scientific and public community of the rapidly growing science on epigenetic regulation as it relates to pediatrics.
To explore the contribution of pediatric environmental exposures to epigenetic regulation and how they vary by exposure, timing and host characteristics, including among disadvantaged populations.
To identify research gaps in the epigenetic literature, especially those that relate to characteristics of environmental exposures (dose, timing) and host (diet, age).
To foster collaborations among scientists and the public to conduct research and to translate research findings on epigenetic regulation important to pediatric health outcomes (i.e. the etiology and prevention of abnormal neurodevelopment, asthma/allergy, obesity, endocrine disorders, etc.) to relevant sectors including public health, medical, policy, and business.

Who Should Attend?

This conference is intended for research scientists in the fields of environmental health, epidemiology, and environmental toxicology, as well as for public health professionals. Students in these disciplines are encouraged to register.

More Information:

Call: 202-543-4033

International Congress of Toxicology 2013 (ICT 2013)

Translational Toxicology: From Basic Science to Clinical and Environmental Outcomes

Seoul, Korea, June 30 ~ July 4, 2013

This congress will offer you many opportunities to exchange advanced knowledge on Toxicology. This year’s congress will be comprised of keynote lectures given by world-renowned scholars, in addition to symposiums, workshops, debates, as well as oral and poster sessions.